MEM.AX

Memphasys Limited MEM.AX

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode MEM.AX BGT.AX IXC.AX CHM.AX HIQ.AX PER.AX CAN.AX BIT.AX IVX.AX ACR.AX
6M -20.00 % 16.00 % 85.71 % -40.00 % -12.00 % -10.00 % -12.50 % 33.33 % -9.00 % -39.13 %
YTD -60.00 % -32.56 % 85.71 % -57.14 % -54.17 % 12.50 % -63.16 % -74.60 % -66.54 % -57.58 %
1Y -42.86 % -47.27 % 58.54 % -66.67 % -8.33 % -88.61 % -65.00 % -80.95 % -54.50 % -73.58 %
3Y -76.80 % -78.52 % -78.69 % -96.55 % -33.41 % -84.75 % -94.48 % -89.74 % -54.50 % -83.53 %
5Y -96.19 % -82.94 % -86.02 % -98.94 % -86.39 % -84.75 % -96.02 % -94.76 % -54.50 % -92.22 %
10Y -98.82 % -85.50 % -87.96 % -98.94 % -86.39 % -84.75 % -97.69 % -89.71 % -54.50 % -98.21 %
From the beginning -99.92 % -85.50 % -87.96 % -98.94 % -86.39 % -84.75 % -97.69 % -98.94 % -54.50 % -98.60 %

Dividend

Invex Therapeutics Ltd

Acrux Limited